[Evaluation of the efficacy of the Baveno VI criteria in diagnosing clinically significant portal hypertension under different etiologic control statuses]. [PDF]
Fang SY +6 more
europepmc +1 more source
[Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region]. [PDF]
Wang ZG +14 more
europepmc +1 more source
[Prediction of the occurrence risk of progressive liver fibrosis in patients with metabolic-associated fatty liver disease based on the SMOTE algorithm and nomogram]. [PDF]
Luo YL +6 more
europepmc +1 more source
[Changes in hepatic phase Ⅱ detoxification enzymes and their mechanism in metabolic associated steatohepatitis (MASH) induced by MCD diet in mice]. [PDF]
Gao JQ +6 more
europepmc +1 more source
[Research progress in liver cancer in 2025]. [PDF]
Miao TG, Nan YM.
europepmc +1 more source
[Expert consensus on the management process within medical institutions for patients with hepatitis B virus infection]. [PDF]
Author Group of Expert Consensus.
europepmc +1 more source
[Characterization of liver macrophage subsets in different mouse models of metabolic associated steatohepatitis]. [PDF]
Xia EZ +8 more
europepmc +1 more source
[Expert consensus on the diagnosis, treatment, and management of liver nodules (version 2026)]. [PDF]
Infectious Diseases Prevention and Control Branch +1 more
europepmc +1 more source
[Analysis of the impact of tumor diameter on short-term prognosis in patients with hepatitis B-related hepatocellular carcinoma-inducing acute-on-chronic liver failure]. [PDF]
Peng YH +9 more
europepmc +1 more source

